Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search results
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Early results from clinical testing of a gene therapy to treat X-linked retinitis pigmentosa (XLRP) have shown partial reversal of sight loss in some patients.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.
Dr Graham undertook research into the basic mechanisms of retinal vasculitis, inflammation of the blood vessels in the retina, and is an important cause of poor vision in patients with uveitis, inflammation of the uveal tract.
Back for 2023, the virtual TCS London Marathon lets you join our team close to home and get your marathon medal!
Support Retina UK and take on three of the highest, most iconic peaks in Wales within 24 hours, with The Welsh Three Peaks Challenge.
Take on Ben Nevis and be rewarded with the feeling that you have just hiked the UK’s highest mountain for Retina UK.
Find out about our upcoming events. Whether you're looking for a webinar, a local peer support group or you're hoping to run a marathon, we've got something for you.
Are you affected by inherited sight loss? We are here to help.